Response to "Nephrotoxicity: Evidence in Patients Receiving Cisplatin Therapy".

An article by Duffy, Fitzgerald, Boyle, and Rohatgi (2018) was published in the April issue of the Clinical Journal of Oncology Nursing. Based on review, the authors suggested some clinical recommendations to protect the kidneys against cisplatin-induced nephrotoxicity, including hydration or supplementation of magnesium or mannitol during cisplatin administration. In addition to clinical findings, the related basic sciences data may be helpful in formulating treatment guidelines in cisplatin therapy. This letter will present several suggestions for future clinical studies based on laboratory findings.

• Publication year

  2018

• Venue

  Clinical Journal of Oncology Nursing

• Publication date

  2018-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1188/18.CJON.477-478PMID 30239517
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nephrotoxicity

  2018cited by this paper
• Age and Gender Related Renal Side Effects of Cisplatin in Animal Model

  2017cited by this paper
• Cisplatin-Induced Nephrotoxicity; Protective Supplements and Gender Differences

  2017cited by this paper
• Nephroprotective effect of estrogen and progesterone combination on cisplatin-induced nephrotoxicity in ovariectomized female rats

  2016cited by this paper
• Protective effect of riboflavin on cisplatin induced toxicities: a gender-dependent study.

  2015cited by this paper
• Gender Differences Influence Renal Injury in Cisplatin-Treated Rats: Biochemical Evaluation

  2014cited by this paper
• Gender Difference in Cisplatin-Induced Nephrotoxicity in a Rat Model: Greater Intensity of Damage in Male Than Female

  2013cited by this paper
• Effect of Oral Administration of Magnesium on Cisplatin-Induced Nephrotoxicity in Normal and Streptozocin-Induced Diabetic Rats

  2013cited by this paper
• The Role of Angiotensin II Receptor 1 (AT1) Blockade in Cisplatin-Induced Nephrotoxicity in Rats: Gender-Related Differences

  2012cited by this paper
• Vitamin E, Vitamin C, or Losartan Is Not Nephroprotectant against Cisplatin-Induced Nephrotoxicity in Presence of Estrogen in Ovariectomized Rat Model

  2012cited by this paper
• The Role of Magnesium Supplementation in Cisplatin-induced Nephrotoxicity in a Rat Model: No Nephroprotectant Effect

  2012cited by this paper
• The protective role of endogenous nitric oxide donor (L-arginine) in cisplatin-induced nephrotoxicity: Gender related differences in rat model

  2011cited by this paper

• Efficacy of SGLT-2 Inhibitors in Preventing Cisplatin-induced Kidney Injury in Patients With Diabetes

  2025cites this paper
• Underpinning the role of natural products against cisplatin-induced nephrotoxicity in rodent models

  2025cites this paper
• Vildagliptin Nephroprotective Effect in Rats Model with Cisplatin-Induced Nephrotoxicity

  2024cites this paper
• Reflections on the Past Decade in Evidence-Based Practice Within the Children's Oncology Group

  2024cites this paper
• Evaluation of a new score associated with acute kidney injury in patients treated with cisplatin based EXTREME regimen

  2024cites this paper
• Roxadustat protects rats from cisplatin-induced acute kidney injury

  2024cites this paper
• Analysis of pharmaceutical interventions in chemotherapy prescriptions of adult and pediatric patients at an oncology reference institute

  2024cites this paper
• Sodium thiosulfate does not protect ovarian reserve from cisplatin-induced gonadotoxicity

  2024cites this paper
• Natural products: potential treatments for cisplatin-induced nephrotoxicity

  2021cites this paper